Poliomyelitis (Live) Vaccine Type Ⅰ Type Ⅲ (Human Diploid Cell) (Beijing Institute Of Biological Products)

Ⅰ型Ⅲ型脊髓灰质炎减毒活疫苗（人二倍体细胞）（北京生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePoliomyelitis (Live) Vaccine Type Ⅰ Type Ⅲ (Human Diploid Cell) (Beijing Institute Of Biological Products)

Drug Alias NameN/A

ClassificationVaccines > National Immunization Program > Immunization program vaccine(Class I)Vaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPoliomyelitis

Global Approved IndicationsPoliomyelitis

Approved Indications in ChinaPoliomyelitis

Original Approved Country/TerritoryMainland China

Original Approved Date2015/11/19

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesBeijing Institute Of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsPoliomyelitis

Inactive IndicationsN/A

Other Information

ATC CodeJ07BF04